Mundipharma
is an England-based pharmaceutical company that accelerates the development of medicines for patients and healthcare providers... Read moreMundipharma
is an England-based pharmaceutical company that accelerates the development of medicines for patients and healthcare providers... Read more
News
Apr 08, 2025
Openpr
Mundipharma: Future of Cancer Pain Market Size, Share & Trends 2024-2031 | Most Leading Companies - CK Life Sciences (WEX Pharmaceuticals Inc), Mundipharma International., Orexo AB
Feb 20, 2025
Business Wire
Press Release: Mundipharma : New global guideline published on managing fungal infections caused by Candida
Feb 06, 2025
Openpr
Mundipharma: Cancer Pain Market is expected to reach US$ 11.02 billion by 2031, growing at a CAGR of 5.6% - Mundipharma International., Orexo AB, DAIICHI SANKYO COMPANY.
Sep 16, 2024
Openpr
Mundipharma: Rapid Growth in Global Inhalable Drugs Market Overall Study Report 2024-2031 |GSK plc., Mundipharma International., Boehringer Ingelheim International GmbH., Cipla Inc.
Jul 03, 2024
Korea Biomedical Review
Mundipharma: Samjin Pharm and Mundipharma Korea to co-promote Norspan patch
Apr 25, 2024
Pharamceutical Technology
Mundipharma: Mundipharma to acquire rezafungin assets from Cidara Therapeutics
Apr 25, 2024
Pharmacy Business
Mundipharma: Mundipharma empowers global healthcare access with acquisition of Rezafungin rights
Apr 23, 2024
Pharmacy Business
Mundipharma: Mundipharma, Vectura collaborate to reformulate asthma inhaler to reduce carbon footprint
Feb 12, 2024
centralcharts
Press Release: Mundipharma : Cidara Therapeutics Receives $11.14 Million Milestone Payment Following European Approval of REZZAYO
Feb 12, 2024
Nasdaq
Mundipharma: Cidara Receives Milestone Payment From Mundipharma On European Approval Of REZZAYO
Mundipharma Competitors
1
2
3
4
5
6
7
8
9
10